Diabetes & Metabolism Journal

Search

Page Path

HOME
Search

Responses

Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7): Sung Hye Kong, Bo Kyung Koo, Min Kyong Moon; Diabetes Metab J. 2019;43(6):913-914. Published online December 26, 2019; DOI: https://doi.org/10.4093/dmj.2019.0149; Full text PubReader Crossref - TDM PDF

Short Communications

Clinical Diabetes & Therapeutics

Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus: Sung Hye Kong, Bo Kyung Koo, Min Kyong Moon; Diabetes Metab J. 2019;43(5):711-717. Published online March 20, 2019; DOI: https://doi.org/10.4093/dmj.2018.0208
Cited By 7; Full text PubReader Crossref - TDM PDF

Response

Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30): Sung Hye Kong, Bo Kyung Koo, Min Kyong Moon; Diabetes Metab J. 2017;41(2):152-153. Published online April 14, 2017; DOI: https://doi.org/10.4093/dmj.2017.41.2.152
Cited By 1; Full text PubReader Crossref - TDM PDF

Original Articles

Clinical Care/Education

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus: Sung Hye Kong, Bo Kyung Koo, Min Kyong Moon; Diabetes Metab J. 2017;41(1):23-30. Published online December 16, 2016; DOI: https://doi.org/10.4093/dmj.2017.41.1.23
Cited By 7; Full text PubReader Crossref - TDM PDF

Volume 46, No. 6

Diabetes &
Metabolism
Journal

Print ISSN: 2233-6079
Online ISSN: 2233-6087

MOST CITED MOST VIEWED

65,535	Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study
65,535	Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study
65,535	Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study
13,755	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
12,950	Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status

Cited By 100	Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
Cited By 64	Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports
Cited By 64	The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
Cited By 55	2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
Cited By 43	Mitochondrial Mechanisms in Diabetic Cardiomyopathy

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2022 by Korean Diabetes Association.